You're reading the free version. Trader adds the live tape and alerts.
Start tracking
URGN Exercise Disclosure
Schoenberg Mark · SEC Form 4 · Filed Jun 9, 2026
Exercise
Reported value range
Not reported
Schoenberg Mark Chief Medical Officer
URGN
UroGen Pharma Ltd
URGN
Transaction date
Jun 8, 2026
Public filing date
Jun 9, 2026
Filing lag
Filed 1 day later
URGN daily price context
Close on/before transaction
$27.25
Jun 8, 2026
First close after public filing
$28
Jun 10, 2026
30-day return after filing
+43.68%
Through Jul 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Ordinary Shares
- Quantity / price
- 10,000 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001437749-26-019964
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$142.56K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Urogen Pharma Ltd. URGN Current | Exercise | Jun 8, 2026 | Not reported |
| Urogen Pharma Ltd. URGN | Sale | Jun 8, 2026 | $142.56K |
| Urogen Pharma Ltd. URGN | Exercise | Jun 8, 2026 | $0 |